Comparison of Synthetic High Density Lipoprotein (HDL) Contrast Agents for MR Imaging of Atherosclerosis-Reference-Cited by-同舟云学术

Comparison of Synthetic High Density Lipoprotein (HDL) Contrast Agents for MR Imaging of Atherosclerosis

Published:2009-04-20 Issue:5 Volume:20 Page:937-943
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Cormode David P.¹,Chandrasekar Rohith¹,Delshad Amanda¹,Briley-Saebo Karen C.¹,Calcagno Claudia¹,Barazza Alessandra¹,Mulder Willem J. M.¹,Fisher Edward A.¹,Fayad Zahi A.¹

Affiliation:

1. Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1234, New York, New York 10029, The Cooper Union for the Advancement in Science and Art, 30 Cooper Square, New York, New York 10003, and Department of Medicine (Cardiology), Marc and Ruti Bell Vascular Biology and Disease Program and the NYU Center for the Prevention of Cardiovascular Disease, New York University School of Medicine, New York University, Smilow 8 522 First Avenue, New York, New...

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/bc800520d

Reference30 articles.

1. Low Priority of Cardiovascular and Chronic Diseases on the Global Health Agenda

2. From Vulnerable Plaque to Vulnerable Patient

3. Molecular, cellular and functional imaging of atherothrombosis

4. Imaging of atherosclerotic cardiovascular disease

5. Molecular Imaging of Cardiovascular Disease

Cited by 63 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potentials of peptide-derived nanoformulations in atherosclerosis: present status and future directions;International Journal of Smart and Nano Materials;2024-07-02

2. Advanced targeted nanomedicines for vulnerable atherosclerosis plaque imaging and their potential clinical implications;Frontiers in Pharmacology;2022-10-13

3. Understanding the Exchange of Systemic HDL Particles Into the Brain and Vascular Cells Has Diagnostic and Therapeutic Implications for Neurodegenerative Diseases;Frontiers in Physiology;2021-09-06

4. Nanoengineering Apolipoprotein A1‐Based Immunotherapeutics;Advanced Therapeutics;2021-06-19

5. (r)HDL in theranostics: how do we apply HDL's biology for precision medicine in atherosclerosis management?;Biomaterials Science;2021